Results 221 to 230 of about 2,559,166 (272)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

The patient participation puzzle: Organizing patient participation in health care networks. [PDF]

open access: yesHealth Care Manage Rev
van der Ven RGFM   +7 more
europepmc   +1 more source

Evaluating a virtual paediatric adverse drug reaction clinic

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck   +2 more
wiley   +1 more source

BRIGHT pathways: recommendations to improve the developmental follow-up of children with CHD in Canada - protocol for a nominal group study. [PDF]

open access: yesBMJ Open
Bolduc ME   +10 more
europepmc   +1 more source

Evaluation of patient safety culture education program among healthcare professionals: A cross-sectional study. [PDF]

open access: yesJ Educ Health Promot
Baby D   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy